Case Study 2: The Case of John John, a 52-year-old male with a history of obesity, started on semaglutide as part of a comprehensive weight management program
Epitalon may not be appropriate if you have active cancer , a recent history of malignancy, or are pregnant/breastfeeding
Biomarkers for Alzheimers disease in the current state: a narrative review
Forneris CA, Nussbaumer-Streit B, Morgan LC, et al
Another technique to enhance the regenerative capacity of cells is to remove neighboring senescent cells
What we found for the very first time, after three and a half to four years of treatment, is that if we add semaglutide to that individual, we can reduce their chance of either dying of cardiovascular disease, having a second stroke, or a second heart attack by 20%